Showing results (271-280 of 334) with videos related to

Sort By:
Pageof 34
Bratislavske Lekarske Listy|May 18, 2021
Triggering receptor expressed on myeloid cells 1 and 2 in patients with chronic maxillary sinusitisM Tedla, M Suchankova, K Ahrendt, et al.
Frontiers in Neuroscience|July 5, 2022
Interpersonal Family Dynamics Relate to Hippocampal CA Subfield StructureChristine Coughlin, Eliya Ben-Asher, Hannah E Roome, et al.
Immunology Letters|November 1, 1995
In vitro complement activation by ragweed allergen extract in the sera of ragweed allergic and non-allergic personsT Hidvégi, B Schmidt, L Varga, et al.
Allergy|October 3, 2012
Short-term prophylaxis in hereditary angioedema due to deficiency of the C1-inhibitor--a long-term surveyH Farkas, Z Zotter, D Csuka, et al.
British Journal of Cancer|May 19, 2000
Antagonists of growth hormone-releasing hormone (GH-RH) inhibit IGF-II production and growth of HT-29 human colon cancersK Szepeshazi, A V Schally, K Groot, et al.
Orvosi Hetilap|October 2, 1994
[Effect of lovastatin on serum lipids and lipoproteins. Hungarian multicenter, open-label study]L Romics, I Karádi, M Csanády, et al.
The Prostate|March 9, 2005
Antagonists of growth hormone releasing hormone (GHRH) and of bombesin/gastrin releasing peptide (BN/GRP) suppress the expression of VEGF, bFGF, and receptors of the EGF/HER family in PC-3 and DU-145 human androgen-independent prostate cancersAnton Stangelberger, Andrew V Schally, Jozsef L Varga, et al.
Molecular Medicine (Cambridge, Mass.)|July 14, 2009
The immunohistochemical expression of growth hormone-releasing hormone receptor splice variant 1 is a favorable prognostic marker in colorectal cancerElena Theophanous, Constantina Petraki, Andreas Scorilas, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 25, 2005
Antagonist of growth hormone-releasing hormone induces apoptosis in LNCaP human prostate cancer cells through a Ca2+-dependent pathwayZoltan Rekasi, Tamas Czompoly, Andrew V Schally, et al.
Cancer|July 14, 2011
Novel antagonists of growth hormone-releasing hormone inhibit growth and vascularization of human experimental ovarian cancersAnna Klukovits, Andrew V Schally, Luca Szalontay, et al.
Pageof 34